Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 36kWORD 9k
15 September 2020
E-005028/2020
Question for written answer E-005028/2020
to the Commission
Rule 138
Robert Roos (ECR), Rob Rooken (ECR)
 Answer in writing 
 Subject: Antibody testing

The Commission has published recommendations for testing strategies. It is also promoting dialogue with Member States at several levels, ensuring the exchange of information, the monitoring and coordination of testing strategies, and testing capacity. Furthermore together with many Member States, the Commission has launched joint procurement tenders for testing materials. In light of this, we would like to ask the following question:

Could the Commission please describe the situation of antigen testing in the Member States?

Last updated: 30 September 2020Legal notice - Privacy policy